Reimagining medicine in cancer
We have the passion and the people to help transform lives as we pursue treatments for patients.
Core disease areas
At Novartis, we push the limits of science to develop innovative therapies. These therapies have the potential to be new foundations for cancer care in areas with great unmet need.
Breast cancer
Novartis aims to tackle breast cancer with bold science, collaboration, and a passion for transforming patient care. We take a bold approach to our research by including patient populations who are often neglected in clinical trials, identifying new pathways or mutations that may play a role in disease progression, and developing therapies to help extend and improve the lives of patients.
Lung cancer
Lung cancer is one of the most common cancers worldwide, accounting for more than 2 million new cases diagnosed each year. Novartis is committed to helping the lung cancer community by advancing the science to drive new treatments for lung cancer.
Prostate cancer
We are harnessing the innovation of our world-class scientists, strategic partnerships, and one of the industry’s most competitive pipelines to explore the potential of our targeted therapies to address unmet needs in prostate cancer. Our goal is to reduce the global disease burden, extend the lives of patients with prostate cancer, and elevate current standards of care.
Solid tumors stories
Helping people solve problems
A conversation with Reshema Kemps-Polanco – Executive Vice President, Oncology IM US.
When you think of the word ‘cancer,’ what are the first words that spring to mind?
Fighter. Hero. Cancer-stricken. The words and metaphors people use to talk about cancer often feel worlds apart from any other disease. But how far does it go? Do words matter?
Prostate cancer and support of the care partner – Carl and Arlene’s story
When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.
Let’s Talk About The C-Word
Talking about cancer can be challenging. Hear from one patient who was inspired to drive change.
Prostate Cancer: A collective commitment to serving underserved communities
Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.
Addressing racial disparities in breast cancer screening
Novartis today announced the launch of More Than JustWords, a multiyear commitment to promote health equity in breast cancer.
Latest cancer news
Novartis Pluvicto™ shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting
Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Novartis to present new oncology data at ESMO 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer
Clinical trials and pipeline projects
Find solid tumors-related clinical trials and learn more about the projects in development around solid tumors.
Related links
Learn more about the other Novartis core therapeutic areas